
|Slideshows|February 16, 2021
- MHE February 2021
- Volume 31
- Issue 2
Challenges Ahead in 2021
Author(s)MHE Staff
COVID-19 is the biggest one, but other twists and turns await.
Advertisement
We conducted our Challenges Ahead reader survey in January and had 101 respondents. Their answers provide understanding and insight into the thinking of healthcare executives about what lies ahead for them, their organizations and the country in 2021. Many thanks to everyone who participated!
Articles in this issue
over 5 years ago
Does the U.S. Have a Shortage of Physicians?over 5 years ago
Risky Business: Only Three of the ACA’s 23 co-ops Remainover 5 years ago
SDOH: How They Affect Cancer Rates, Care and Paymentover 5 years ago
Interoperability is Coming — at Lastover 5 years ago
Using Behavioral Economics to Influence Healthcare Decisionsover 5 years ago
Next Gen ACOs: Savers or Spenders?over 5 years ago
COVID Vaccines OK for Immunocompromisedover 5 years ago
Plot Twists for ‘Mabs’ as COVID-19 TreatmentAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Langlara, third interchangeable biosimilar to Lantus, approved by FDA
2
Cancer patients taking GLP-1s less likely to develop advanced disease | ASCO 2026
3
FDA approves first treatment for chronic hepatitis D virus
4
Nubeqa edges Xtandi on cognitive side effects | ASCO 2026
5






















